| LncRNAs: emerging biomarkers in gastric cancer Y Gu, T Chen, G Li, X Yu, Y Lu, H Wang, L Teng Future oncology 11 (17), 2427-2441, 2015 | 122 | 2015 |
| Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells G Li, J Zhang, K Jin, K He, Y Zheng, X Xu, H Wang, H Wang, Z Li, X Yu, ... Molecular oncology 7 (3), 611-624, 2013 | 91 | 2013 |
| Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA sequencing H Jiang, D Yu, P Yang, R Guo, M Kong, Y Gao, X Yu, X Lu, X Fan Clinical and translational medicine 12 (2), e730, 2022 | 90 | 2022 |
| Gut microbiota shifts in patients with gastric cancer in perioperative period W Liang, Y Yang, H Wang, H Wang, X Yu, Y Lu, S Shen, L Teng Medicine 98 (35), e16626, 2019 | 87 | 2019 |
| LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling H Wang, M Wu, Y Lu, K He, X Cai, X Yu, J Lu, L Teng Aging (Albany NY) 11 (17), 6657, 2019 | 70 | 2019 |
| Poorer Prognosis and Higher Prevalence of BRAF V600E Mutation in Synchronous Bilateral Papillary Thyroid Carcinoma W Wang, W Zhao, H Wang, X Teng, H Wang, X Chen, Z Li, X Yu, TJ Fahey, ... Annals of surgical oncology 19, 31-36, 2012 | 68 | 2012 |
| Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma … H Jiang, X Yu, N Li, M Kong, Z Ma, D Zhou, W Wang, H Wang, H Wang, ... Journal for immunotherapy of cancer 10 (3), 2022 | 59 | 2022 |
| Estrogen-independent effects of ER-α36 in ER-negative breast cancer J Zhang, G Li, Z Li, X Yu, Y Zheng, K Jin, H Wang, Y Gong, X Sun, X Teng, ... Steroids 77 (6), 666-673, 2012 | 56 | 2012 |
| Prognostic role of C-reactive protein in gastric cancer: a meta-analysis Q Yu, XF Yu, SD Zhang, HH Wang, HY Wang, LS Teng Asian Pacific Journal of Cancer Prevention 14 (10), 5735-5740, 2013 | 54 | 2013 |
| miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer S Wang, Y Chen, X Yu, Y Lu, H Wang, F Wu, L Teng Pathology-Research and Practice 215 (4), 676-682, 2019 | 50 | 2019 |
| Advances in the targeted therapy of liposarcoma Z Guan, X Yu, H Wang, H Wang, J Zhang, G Li, J Cao, L Teng OncoTargets and therapy, 125-136, 2015 | 40 | 2015 |
| Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets J Lu, Y Ding, Y Chen, J Jiang, Y Chen, Y Huang, M Wu, C Li, M Kong, ... Nature Communications 12 (1), 3946, 2021 | 38 | 2021 |
| A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics H Wang, Y Ding, Y Chen, J Jiang, Y Chen, J Lu, M Kong, F Mo, Y Huang, ... Gastric Cancer 24, 1227-1241, 2021 | 29 | 2021 |
| Gastritis cystica profunda in a previously unoperated stomach: a case report XF Yu, LW Guo, ST Chen, LS Teng World Journal of Gastroenterology: WJG 21 (12), 3759, 2015 | 29 | 2015 |
| Extranodal follicular dendritic cell sarcoma in mesentery: A case report Z Li, K Jin, X Yu, X Teng, H Zhou, Y Wang, L Teng, F Cao Oncology Letters 2 (4), 649-652, 2011 | 29 | 2011 |
| HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer X Jiang, M Wu, Z Xu, H Wang, H Wang, X Yu, Z Li, L Teng Cancer management and research, 6857-6867, 2018 | 22 | 2018 |
| Prognostic value of the combination of CEA and fibrinogen/albumin ratio in resectable gastric cancer J Zhang, J Ruan, W Wang, Y Lu, H Wang, X Yu, H Wang, L Teng Cancer management and research, 2767-2775, 2020 | 21 | 2020 |
| The prognostic value of intermedin in patients with breast cancer YM Lu, JB Zhong, HY Wang, XF Yu, ZQ Li Disease markers 2015 (1), 862158, 2015 | 17 | 2015 |
| Indocyanine green clearance in evaluating the recovery of liver reserve function after superselective transarterial chemoembolization X Chen, HB Zhang, ZQ Li, XF Yu, MF Yang, HH Wang, LS Teng Hepatobiliary & Pancreatic Diseases International 12 (6), 656-660, 2013 | 13 | 2013 |
| Sintilimab plus oxaliplatin/capecitabine (CapeOx) as neoadjuvant therapy in patients with locally advanced, resectable gastric (G)/esophagogastric junction (GEJ) adenocarcinoma. H Jiang, X Yu, M Kong, Z Ma, D Zhou, W Wang, H Wang, N Li, H Wang, ... Journal of Clinical Oncology 39 (3_suppl), 211-211, 2021 | 12 | 2021 |
